Preeclampsia and Cardiovascular Risk for Offspring

Wiktor Wojczakowski1, Żaneta Kimber-Trojnar1, Filip Dziwisz2

  • 1Department of Obstetrics and Perinatology, Medical University of Lublin, 20-090 Lublin, Poland.

Insights

Children exposed to preeclampsia in utero face increased risks of cardiovascular disease later in life. This involves fetal and postnatal programming, but clear causal links remain complex to establish.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatrics
  • Cardiovascular Medicine

Background:

  • Preeclampsia is a pregnancy complication associated with maternal hypertension and placental issues.
  • Offspring of mothers with preeclampsia exhibit higher risks for long-term cardiovascular diseases (CVD).
  • Mechanisms involve fetal and postnatal programming, influenced by genetic, molecular, and environmental factors.

Purpose of the Study:

  • To discuss the association between preeclampsia during pregnancy and the potential for cardiovascular disease in offspring.
  • To explore the complex interplay of factors contributing to this risk.

Main Methods:

  • Literature review and synthesis of existing evidence.
  • Discussion of proposed mechanisms including fetal programming and environmental influences.

Main Results:

  • Growing evidence links in utero preeclampsia exposure to later-life cardiovascular sequelae in children.
  • Increased risks observed include hypertension, stroke, and diabetes in offspring.
  • The multifactorial nature of CVD development complicates the establishment of direct dependency mechanisms.

Conclusions:

  • Pregnancy complicated by preeclampsia poses a significant long-term cardiovascular risk to offspring.
  • Understanding fetal and postnatal programming is crucial for risk assessment.
  • Further research is needed to fully elucidate the direct causal pathways between preeclampsia and offspring CVD.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
78
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
34.3K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
130
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
114